|
LRRC42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.485550E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.819420E-01 |
| Normal-vs-Stage2 |
3.344500E-02 |
| Normal-vs-Stage3 |
1.864130E-03 |
| Normal-vs-Stage4 |
8.594400E-02 |
| Stage1-vs-Stage2 |
1.334450E-01 |
| Stage1-vs-Stage3 |
1.114310E-02 |
| Stage1-vs-Stage4 |
3.588400E-01 |
| Stage2-vs-Stage3 |
7.126200E-01 |
| Stage2-vs-Stage4 |
5.892800E-01 |
| Stage3-vs-Stage4 |
2.889800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.784100E-03 |
| Normal-vs-AfricanAmerican |
9.001600E-02 |
| Normal-vs-Asian |
2.621800E-01 |
| Caucasian-vs-AfricanAmerican |
8.555800E-01 |
| Caucasian-vs-Asian |
1.407010E-01 |
| AfricanAmerican-vs-Asian |
1.405830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.155500E-04 |
| Normal-vs-Female |
8.426800E-01 |
| Male-vs-Female |
1.41350000004703E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.026800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.901750E-02 |
| Normal-vs-Age(61-80Yrs) |
3.976200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.448600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.244600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.359000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.994800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.360200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.036600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.009800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.839400E-01 |
| Normal-vs-Grade 2 |
2.876800E-01 |
| Normal-vs-Grade 3 |
1.899040E-03 |
| Normal-vs-Grade 4 |
2.050100E-02 |
| Grade 1-vs-Grade 2 |
4.904000E-01 |
| Grade 1-vs-Grade 3 |
1.220810E-01 |
| Grade 1-vs-Grade 4 |
1.707020E-01 |
| Grade 2-vs-Grade 3 |
9.661700E-03 |
| Grade 2-vs-Grade 4 |
6.093700E-02 |
| Grade 3-vs-Grade 4 |
9.778000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.959200E-01 |
| Normal-vs-ccB subtype |
1.355520E-04 |
| ccA subtype-vs-ccB subtype |
2.34119999997784E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.161600E-02 |
| Normal-vs-N1 |
4.105000E-01 |
| N0-vs-N1 |
9.106600E-01 |
|
|
